Abstract:The formation of amyloid fibrils by alpha-synuclein (alpha S) protein inside the Lewy bodies and Lewy neurites is the prominent pathological hallmark of Parkinson's disease (PD). The fibrillation of alpha S in vitro is described by a nucleation-elongation process involving the formation of a critical nucleus. Finding the critical/smallest nuclei and effective inhibitors of alpha S aggregation is a crucial step for the development of drugs against PD. Recent experiments reported that dopamine (DA) and norepinephrine (NE), two prominent naturally occurring neurotransmitters, can effectively disrupt the preformed alpha S fibrils. The level of DA/NE in blood can be markedly increased by exercise. However, the size and structure of the critical nucleus and the disruptive mechanism by DA/NE are largely unknown. In this work, we performed multiple molecular dynamics (MD) simulations to find the critical nucleus size and examine the influences of DA/NE molecules on preformed alpha S44-96 (Greek-key-like core of full length alpha S) protofibrils. Our results show that the trimer is the critical nucleus for the alpha S44-96 fibril formation, and the tetramer is the minimal stable nucleus. When DA/NE molecules bind to the fibril-like trimer and tetramer, they strongly destabilize the alpha S protofibrils by disrupting the beta-sheet structure and inter-chain E46-K80 salt bridges. Two common binding sites are identified for both DA and NE molecules on alpha S oligomers: residues 57-70 and 81-83. A different binding site is also observed, which is located at the N-terminal region (residues 45-52). The binding of DA/NE molecules to alpha S oligomers is mostly driven by hydrophobic and electrostatic interactions. We found two disruptive modes, and binding to the turn region of alpha S oligomers but disrupting the adjacent beta-sheet structure is the dominant one. Our work identified the critical nucleus of Greek-key-like core of alpha S protofibrils and revealed the disruptive mechanism of alpha S protofibrils by DA/NE molecules, which may be helpful to the design of effective drugs against alpha S aggregation.

Global kinetic model of lipid-induced alpha-synuclein aggregation and its inhibition by small molecules

Molecular mechanism of α-synuclein aggregation on lipid membranes revealed

Real-time Determination of Aggregated Alpha-Synuclein Induced Membrane Disruption at Neuroblastoma Cells Using Scanning Ion Conductance Microscopy.

Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis

Probing the molecular mechanisms of α-synuclein inhibitors unveils promising natural candidates through machine-learning QSAR, pharmacophore modeling, and molecular dynamics simulations

Structural characterisation of α-synuclein -membrane interactions and the resulting aggregation using small angle scattering

α-synuclein oligomers displace monomeric α-synuclein from lipid membranes

Identifying Oligomers and Lipid Vesicles Effects During Α-Synuclein Fibril Formation Through a Solid-State Nanopore

The Role of Alpha Synuclein in Synucleinopathy: Impact on Lipid Regulation at Mitochondria ER Membranes

The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition

Protein mimetic 2D FAST rescues alpha synuclein aggregation mediated early and post disease Parkinson’s phenotypes

Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors

Critical nucleus of Greek-key-like core of α-synuclein protofibril and its disruption by dopamine and norepinephrine.

Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of Α-Synuclein Amyloids in Parkinson's Disease

3,4‐Dihydroxyphenylethanol and 3,4‐dihydroxyphenylacetic acid affect the aggregation process of E46K variant of α‐synuclein at different extent: Insights into the interplay between protein dynamics and catechol effect

Lipids and α-Synuclein: adding further variables to the equation

The influence of Zwitterionic and anionic phospholipids on protein aggregation

Effects of Lanthionine Ketimine-5-Ethyl Ester on the α-Synucleinopathy Mouse Model

Kinetic models reveal the interplay of protein production and aggregation

Residues 2-7 of alpha-synuclein regulate amyloid formation via lipid-dependent and -independent pathways